Reduced E-cadherin facilitates renal cell carcinoma progression by WNT/β-catenin signaling activation

Reduced expression of E-cadherin was observed in renal cell carcinoma (RCC). However, its potential clinical value and correlation with WNT/β-catenin signaling in RCC progression was still unclear. Immunohistochemical staining was performed in RCC tissue microarray to examine the expression status a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinqi, Yang, Mingxi, Shi, Hua, Hu, Jianxin, Wang, Yuanlin, Sun, Zhaolin, Xu, Shuxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386706/
https://www.ncbi.nlm.nih.gov/pubmed/28223537
http://dx.doi.org/10.18632/oncotarget.15361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386706/
https://www.ncbi.nlm.nih.gov/pubmed/28223537
http://dx.doi.org/10.18632/oncotarget.15361

Ejemplares similares